Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 215

    1.

    Characterization of susceptibility of inbred mouse strains to diabetic nephropathy.

    Qi Z, Fujita H, Jin J, Davis LS, Wang Y, Fogo AB, Breyer MD.

    Diabetes. 2005 Sep;54(9):2628-37.PMID: 16123351 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes.

    Kanetsuna Y, Hirano K, Nagata M, Gannon MA, Takahashi K, Harris RC, Breyer MD, Takahashi T.

    Am J Physiol Renal Physiol. 2006 Dec;291(6):F1315-22. Epub 2006 May 16.PMID: 16705146 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effect of varied protein intake on the nephropathy of the diabetic mouse (C57BL/s J db/db).

    Brouhard BH, Rajaraman S, LaGrone LF.

    Int J Pediatr Nephrol. 1987 Apr-Jun;8(2):59-68.PMID: 3308729 [PubMed - indexed for MEDLINE]Related articles

    4.

    Impact of genetic background on nephropathy in diabetic mice.

    Gurley SB, Clare SE, Snow KP, Hu A, Meyer TW, Coffman TM.

    Am J Physiol Renal Physiol. 2006 Jan;290(1):F214-22. Epub 2005 Aug 23.PMID: 16118394 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice.

    Kanetsuna Y, Takahashi K, Nagata M, Gannon MA, Breyer MD, Harris RC, Takahashi T.

    Am J Pathol. 2007 May;170(5):1473-84.PMID: 17456755 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy.

    Mima A, Arai H, Matsubara T, Abe H, Nagai K, Tamura Y, Torikoshi K, Araki M, Kanamori H, Takahashi T, Tominaga T, Matsuura M, Iehara N, Fukatsu A, Kita T, Doi T.

    Diabetes. 2008 Jun;57(6):1712-22. Epub 2008 Feb 19.PMID: 18285555 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.

    Wolf G, Schanze A, Stahl RA, Shankland SJ, Amann K.

    Kidney Int. 2005 Oct;68(4):1583-9.PMID: 16164635 [PubMed - indexed for MEDLINE]Related articles

    8.

    Can murine diabetic nephropathy be separated from superimposed acute renal failure?

    Tay YC, Wang Y, Kairaitis L, Rangan GK, Zhang C, Harris DC.

    Kidney Int. 2005 Jul;68(1):391-8.PMID: 15954931 [PubMed - indexed for MEDLINE]Related articles

    9.

    Strain differences rather than hyperglycemia determine the severity of glomerulosclerosis in mice.

    Zheng F, Striker GE, Esposito C, Lupia E, Striker LJ.

    Kidney Int. 1998 Dec;54(6):1999-2007.PMID: 9853264 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Effects of sulfonylureas, alpha-endosulfine counterparts, on glomerulosclerosis in type 1 and type 2 models of diabetes.

    Biederman JI, Vera E, Rankhaniya R, Hassett C, Giannico G, Yee J, Cortes P.

    Kidney Int. 2005 Feb;67(2):554-65. Erratum in: Kidney Int. 2005 Mar;67(3):1213. PMID: 15673303 [PubMed - indexed for MEDLINE]Related articles

    11.

    Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.

    Ichinose K, Maeshima Y, Yamamoto Y, Kitayama H, Takazawa Y, Hirokoshi K, Sugiyama H, Yamasaki Y, Eguchi K, Makino H.

    Diabetes. 2005 Oct;54(10):2891-903. Erratum in: Diabetes. 2006 Sep;55(9):2665. PMID: 16186390 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Glomerular hemodynamic and structural alterations in experimental diabetes mellitus.

    O'Donnell MP, Kasiske BL, Keane WF.

    FASEB J. 1988 May;2(8):2339-47. Review.PMID: 3282959 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking the tubuloglomerular feedback mechanism.

    Sällström J, Carlsson PO, Fredholm BB, Larsson E, Persson AE, Palm F.

    Acta Physiol (Oxf). 2007 Jul;190(3):253-9.PMID: 17581137 [PubMed - indexed for MEDLINE]Related articles

    14.

    Development of late-stage diabetic nephropathy in OVE26 diabetic mice.

    Zheng S, Noonan WT, Metreveli NS, Coventry S, Kralik PM, Carlson EC, Epstein PN.

    Diabetes. 2004 Dec;53(12):3248-57.PMID: 15561957 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha.

    Park CW, Kim HW, Ko SH, Chung HW, Lim SW, Yang CW, Chang YS, Sugawara A, Guan Y, Breyer MD.

    Diabetes. 2006 Apr;55(4):885-93.PMID: 16567507 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy.

    de Haan JB, Stefanovic N, Nikolic-Paterson D, Scurr LL, Croft KD, Mori TA, Hertzog P, Kola I, Atkins RC, Tesch GH.

    Am J Physiol Renal Physiol. 2005 Sep;289(3):F544-51. Epub 2005 Apr 12.PMID: 15827346 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats.

    Bardoux P, Martin H, Ahloulay M, Schmitt F, Bouby N, Trinh-Trang-Tan MM, Bankir L.

    Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10397-402.PMID: 10468619 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Animal models of spontaneous diabetic kidney disease.

    Velasquez MT, Kimmel PL, Michaelis OE 4th.

    FASEB J. 1990 Aug;4(11):2850-9. Review.PMID: 2199283 [PubMed - indexed for MEDLINE]Related articles

    19.

    Glomerular injury is exacerbated in diabetic integrin alpha1-null mice.

    Zent R, Yan X, Su Y, Hudson BG, Borza DB, Moeckel GW, Qi Z, Sado Y, Breyer MD, Voziyan P, Pozzi A.

    Kidney Int. 2006 Aug;70(3):460-70. Epub 2006 Jun 14.PMID: 16775606 [PubMed - indexed for MEDLINE]Related articles

    20.

    C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.

    Samnegård B, Jacobson SH, Jaremko G, Johansson BL, Ekberg K, Isaksson B, Eriksson L, Wahren J, Sjöquist M.

    Nephrol Dial Transplant. 2005 Mar;20(3):532-8. Epub 2005 Jan 21.PMID: 15665028 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data